Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
Clinical trial of lithium in Parkinson’s set to begin
We are delighted to announce funding for an upcoming phase1b clinical trial to investigate whether lithium, a drug currently used to treat mood disorders, could be repurposed to slow down Parkinson’s.
Cure Parkinson’s Fundraising Heroes: March and April 2024
Take a look at what our incredible fundraisers got up to in March and April. Putting in the steps to raise funds for our research Friends Tim (who lives with Parkinson’s), Justin and David walked the Norfolk Coast Path back in March, splitting the 112…
Webinar: Inflammation and Parkinson’s
Held in partnership with the University of Edinburgh and the Journal of Parkinson’s Disease, with Edinburgh University’s Professor Tilo Kunath as chair. This hour-long webinar is for the Parkinson’s community and allows the opportunity to hear first-hand from experts in the field, to learn more…
Over £140k raised for Cure Parkinson’s at the 2024 TCS London Marathon
Team Cure hit the streets of London to take part in the gruelling 26.2 mile race. On Sunday 21 April, 44 Cure Parkinson’s supporters ran the iconic TCS London Marathon to raise vital funds and awareness for our research. This year’s Team Cure – which…
Accelerating Parkinson’s drug development: The International Linked Clinical Trials initiative
In 2012, Cure Parkinson’s joined forces with Van Andel Institute (VAI) to hold the first international Linked Clinical Trials (iLCT) meeting in Grand Rapids, Michigan. The Committee has since met annually to evaluate and prioritise drugs for clinical trial in Parkinson’s, a review of which has now been published in the Journal of Parkinson’s Disease.